Terns Pharmaceuticals
Pharmaceutical ManufacturingView the employees at
Terns Pharmaceuticals-
Kenneth Wong Sr Clinical Trial Manager at Terns Pharmaceuticals
-
Singapore
-
Rising Star
Kerry Russell, MD, PhD Chief Medical Officer at Terns Pharmaceuticals-
Boston, Massachusetts, United States
-
Rising Star
Emil Kuriakose, MD Chief Medical Officer, Oncology at Terns Pharmaceuticals-
Greater Houston
-
Rising Star
Jocel Dumlao Associate Director Clinical Operations at Terns Pharmaceutical-
San Francisco
-
Rising Star
Overview
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates to address serious diseases such as NASH, obesity and cancer. Terns’ pipeline includes four clinical stage development programs including a THR-β agonist, an allosteric BCR-ABL inhibitor, an FXR agonist, a VAP-1 inhibitor, and a preclinical small-molecule GLP-1 receptor agonist program. For more information, please visit: www.ternspharma.com.
-